Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin–Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin–Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections

(1) Objectives: To describe the relationship between pharmacokinetic/pharmacodynamic (PK/PD) target attainment of continuous infusion (CI) piperacillin–tazobactam or meropenem monotherapy and microbiological outcome in a case series of urological patients with documented Gram-negative infections. (2...

Full description

Bibliographic Details
Main Authors: Pasquale Maria Berrino, Milo Gatti, Matteo Rinaldi, Eugenio Brunocilla, Pierluigi Viale, Federico Pea
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Antibiotics
Subjects:
piperacillin–tazobactam
meropenem
urology
Gram-negative infections
PK/PD target attainment
microbiological outcome
Online Access:https://www.mdpi.com/2079-6382/12/9/1388

Similar Items

Similar Items